Search
-
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, n° 12, pp. 1981-1990, 2022-10-26)Article de revue -
Alopecia areata: Recent advances and emerging therapies
(Annales de Dermatologie et de Venereologie. vol. 149, pp. 222-227, 2022-06-23)Article de revue -
Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old
(EBioMedicine. vol. 76, pp. 103852, 2022-02-01)Article de revueOpen access -
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
(Cancer Immunology, Immunotherapy. vol. 71, n° 11, pp. 2609-2618, 2022-11)Article de revue -
Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial
(American Journal of Transplantation. vol. 22, n° 5, pp. 1430-1441, 2022-01-01)Article de revue -
Characterization of the novel HLA-C*16:173 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 97, n° 1, pp. 82-83, 2021-01)Article de revue -
Characterization of the novel HLA-DPA1*01:61 allele by sequencing-based typing
(HLA: Immune Response Genetics, 2021-12)Article de revue -
Characterization of the novel HLA-DQB1*06:385 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 98, pp. 73-574. d, 2021)Article de revue -
Clinical relevance of donor-specific antibodies directed at HLA-C: A long road to acceptance
(HLA: Immune Response Genetics. vol. 97, n° 1, pp. 3-14, 2021-01)Article de revue -
Characterization of the novel HLA-DQA1*03:20 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 98, n° 5, pp. 492-494, 2021-05-17)Article de revue